TP53 and carcinoma: Further analysis of TP53 mutations by trinucleotide context demonstrated that TCT>TAT alterations (characteristic of POLEmut carcinomas 26, 32) were uncommon in POLEmut–p53abn ECs (4.2%) and absent in single‐classifier p53abn ECs (0/116) (p = 0.31).